These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 38076365)

  • 41. Complications of Cirrhosis in Primary Care: Recognition and Management of Hepatic Encephalopathy.
    Flamm SL
    Am J Med Sci; 2018 Sep; 356(3):296-303. PubMed ID: 30286824
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of Nutritional Therapy for Patients With Cirrhosis and Minimal Hepatic Encephalopathy in a Randomized Trial.
    Maharshi S; Sharma BC; Sachdeva S; Srivastava S; Sharma P
    Clin Gastroenterol Hepatol; 2016 Mar; 14(3):454-460.e3; quiz e33. PubMed ID: 26453952
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Health-related quality of life in cirrhotic patients: a case-control study.
    Labidi A; Hidri S; Hafi M; Serghini M; Zouiten L; Boubaker J
    Tunis Med; 2019; 97(8-9):990-996. PubMed ID: 32173847
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of and Factors Associated with Sleep-Wake Abnormalities in Patients with Cirrhosis.
    Kumar M; Kainth S; Kumar S; Bhardwaj A; KumarAggarwal H; Maiwall R; Jamwal KD; Shasthry SM; Jindal A; Choudhary A; Anand L; Dhamija RM; Chibbar G; Chander Sharma B; Sarin SK
    J Clin Exp Hepatol; 2021; 11(4):453-465. PubMed ID: 34276152
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Liver Transplant Is Associated with Sustained Improvement in Tandem Gait and Risk of Falls.
    Acharya C; White MB; Fagan A; Sterling RK; Stravitz RT; Puri P; Fuchs M; Luketic V; Sanyal AJ; Wade JB; Gilles H; Heuman DM; Tinsley F; Matherly S; Lee H; Siddiqui MS; Thacker LR; Bajaj JS
    Dig Dis Sci; 2021 Apr; 66(4):1360-1366. PubMed ID: 32323075
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Factors Associated with Health-Related Quality of Life in Korean Patients with Chronic Hepatitis C Infection Using the SF-36 and EQ-5D.
    Jang ES; Kim YS; Kim KA; Lee YJ; Chung WJ; Kim IH; Lee BS; Jeong SH
    Gut Liver; 2018 Jul; 12(4):440-448. PubMed ID: 29588435
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of Hepatic Encephalopathy in Cirrhosis on Quality-of-Life Issues.
    Montagnese S; Bajaj JS
    Drugs; 2019 Feb; 79(Suppl 1):11-16. PubMed ID: 30706419
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rifaximin vs. lactulose in treatment of minimal hepatic encephalopathy.
    Sidhu SS; Goyal O; Parker RA; Kishore H; Sood A
    Liver Int; 2016 Mar; 36(3):378-85. PubMed ID: 26201713
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with current standards of care.
    Bohra A; Worland T; Hui S; Terbah R; Farrell A; Robertson M
    World J Gastroenterol; 2020 May; 26(18):2221-2231. PubMed ID: 32476788
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Frailty, Psychoactive Medications, and Cognitive Dysfunction Are Associated With Poor Patient-Reported Outcomes in Cirrhosis.
    Tapper EB; Baki J; Parikh ND; Lok AS
    Hepatology; 2019 Apr; 69(4):1676-1685. PubMed ID: 30382584
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sarcopenia as a prognostic predictor of liver cirrhosis: a multicentre study in China.
    Zeng X; Shi ZW; Yu JJ; Wang LF; Luo YY; Jin SM; Zhang LY; Tan W; Shi PM; Yu H; Zhang CQ; Xie WF
    J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1948-1958. PubMed ID: 34520115
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Health-related quality of life and psychological correlates in patients listed for liver transplantation.
    Gutteling JJ; de Man RA; Busschbach JJ; Darlington AS
    Hepatol Int; 2007 Dec; 1(4):437-43. PubMed ID: 19669339
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nutritional support for liver disease.
    Koretz RL; Avenell A; Lipman TO
    Cochrane Database Syst Rev; 2012 May; 2012(5):CD008344. PubMed ID: 22592729
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative Efficacy of Treatment Options for Minimal Hepatic Encephalopathy: A Systematic Review and Network Meta-Analysis.
    Dhiman RK; Thumburu KK; Verma N; Chopra M; Rathi S; Dutta U; Singal AK; Taneja S; Duseja A; Singh M
    Clin Gastroenterol Hepatol; 2020 Apr; 18(4):800-812.e25. PubMed ID: 31476436
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis.
    Simón-Talero M; Roccarina D; Martínez J; Lampichler K; Baiges A; Low G; Llop E; Praktiknjo M; Maurer MH; Zipprich A; Triolo M; Vangrinsven G; Garcia-Martinez R; Dam A; Majumdar A; Picón C; Toth D; Darnell A; Abraldes JG; Lopez M; Kukuk G; Krag A; Bañares R; Laleman W; La Mura V; Ripoll C; Berzigotti A; Trebicka J; Calleja JL; Tandon P; Hernandez-Gea V; Reiberger T; Albillos A; Tsochatzis EA; Augustin S; Genescà J;
    Gastroenterology; 2018 May; 154(6):1694-1705.e4. PubMed ID: 29360462
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Health-related quality of life in children with autoimmune liver disease.
    Gulati R; Radhakrishnan KR; Hupertz V; Wyllie R; Alkhouri N; Worley S; Feldstein AE
    J Pediatr Gastroenterol Nutr; 2013 Oct; 57(4):444-50. PubMed ID: 23783017
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targets to improve quality of care for patients with hepatic encephalopathy: data from a multi-centre cohort.
    Bajaj JS; O'Leary JG; Tandon P; Wong F; Kamath PS; Biggins SW; Garcia-Tsao G; Lai J; Fallon MB; Thuluvath PJ; Vargas HE; Maliakkal B; Subramanian RM; Thacker LR; Reddy KR
    Aliment Pharmacol Ther; 2019 Jun; 49(12):1518-1527. PubMed ID: 31032966
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nutrition and Muscle in Cirrhosis.
    Anand AC
    J Clin Exp Hepatol; 2017 Dec; 7(4):340-357. PubMed ID: 29234200
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prospective evaluation of the impact of covert hepatic encephalopathy on quality of life and sleep in cirrhotic patients.
    Labenz C; Baron JS; Toenges G; Schattenberg JM; Nagel M; Sprinzl MF; Nguyen-Tat M; Zimmermann T; Huber Y; Marquardt JU; Galle PR; Wörns MA
    Aliment Pharmacol Ther; 2018 Aug; 48(3):313-321. PubMed ID: 29863286
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epilepsy as a risk factor for hepatic encephalopathy in patients with cirrhosis: a cohort study.
    Jepsen P; Christensen J; Weissenborn K; Watson H; Vilstrup H
    BMC Gastroenterol; 2016 Jul; 16(1):77. PubMed ID: 27457247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.